Professional
Added to YB: 2020-01-08
Pitch date: 2020-01-08
GSK [bullish]
GSK plc
+33.19%
current return
Author Info
Riverwater Partners is a Milwaukee-based investment advisory firm dedicated to responsible investing. Visit the website.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
Market Cap
GBP 72.9B
Pitch Price
GBP 13.70
Price Target
N/A
Dividend
3.36%
EV/EBITDA
8.93
P/E
13.65
EV/Sales
2.70
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Riverwell Partners q4 2019 fund letter - GlaxoSmithKline (GSK)
A summary for this pitch has not been created yet.
Read full article (1 min)